NEUROONE MEDICAL TECHNOLOGIES Corp Annual Net Cash Provided by (Used in) Investing Activities in USD from 2011 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp annual/quarterly Net Cash Provided by (Used in) Investing Activities history and growth rate from 2011 to 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Net Cash Provided by (Used in) Investing Activities for the quarter ending December 31, 2023 was -$37.1K, a 346% decline year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Cash Provided by (Used in) Investing Activities for 2024 was -$120K, a 105% decline from 2023.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Cash Provided by (Used in) Investing Activities for 2023 was $2.65M.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$3.24M, a 4737% decline from 2021.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$120K -$2.77M -105% Oct 1, 2023 Sep 30, 2024 10-K 2024-12-17
2023 $2.65M +$5.89M Oct 1, 2022 Sep 30, 2023 10-K 2024-12-17
2022 -$3.24M -$3.18M -4737% Oct 1, 2021 Sep 30, 2022 10-K 2023-12-15
2021 -$67.1K +$55.3K +45.2% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-22
2020 -$122K +$925 +0.75% Oct 1, 2019 Sep 30, 2020 10-K/A 2022-05-31
2019 -$123K Oct 1, 2018 Sep 30, 2019 10-K 2020-12-09
2017 -$91.7K Jan 1, 2017 Dec 31, 2017 10-KT/A 2019-03-18
2012 $0 $0 Jan 1, 2012 Dec 31, 2012 10-K 2013-04-11
2011 $0 Jan 1, 2011 Dec 31, 2011 10-K 2013-04-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.